Cargando…

Current approaches in identification and isolation of human renal cell carcinoma cancer stem cells

In recent years, cancer stem cells (CSCs)/tumor initiating cells (TICs) have been identified inside different tumors. However, currently used anti-cancer therapies are mostly directed against somatic tumor cells without targeting CSCs/TICs. CSCs/TICs also gain resistance to chemotherapies/radiothera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Mohammed I., Czarnecka, Anna M., Helbrecht, Igor, Bartnik, Ewa, Lian, Fei, Szczylik, Cezary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4574074/ https://www.ncbi.nlm.nih.gov/pubmed/26377541 http://dx.doi.org/10.1186/s13287-015-0177-z

Ejemplares similares

Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells
por: Khan, Mohammed I., et al.
Publicado: (2016)

The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis
por: Myszczyszyn, Adam, et al.
Publicado: (2015)

Biology of renal tumour cancer stem cells applied in medicine
por: Matak, Damian, et al.
Publicado: (2015)

Effects of cell-cell crosstalk on gene expression patterns in a cell model of renal cell carcinoma lung metastasis
por: Kaminska, Katarzyna, et al.
Publicado: (2017)

Thyroid Hormones as Renal Cell Cancer Regulators
por: Szymański, Łukasz, et al.
Publicado: (2016)

Renal cell carcinoma with intramyocardial metastases
por: Czarnecka, Anna M, et al.
Publicado: (2014)

Metastatic renal cell carcinoma cells growing in 3D on poly-D-lysine or laminin present a stem-like phenotype and drug resistance
por: Brodaczewska, Klaudia K., et al.
Publicado: (2019)

Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma
por: Czarnecka, Anna M., et al.
Publicado: (2019)

Vitamin D receptor gene polymorphisms in breast and renal cancer: Current state and future approaches
por: KHAN, MOHAMMED I., et al.
Publicado: (2013)

The role of the cell–cell interactions in cancer progression
por: Kamińska, Katarzyna, et al.
Publicado: (2015)

Mammalian Target of Rapamycin Inhibitors Resistance Mechanisms in Clear Cell Renal Cell Carcinoma
por: Kornakiewicz, Anna, et al.
Publicado: (2013)

Culture in embryonic kidney serum and xeno-free media as renal cell carcinoma and renal cell carcinoma cancer stem cells research model
por: Krawczyk, Krzysztof M., et al.
Publicado: (2018)

Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma
por: Bielecka, Zofia Felicja, et al.
Publicado: (2014)

Metastasis-Initiating Cells in Renal Cancer
por: Khan, Mohammed I., et al.
Publicado: (2013)

Pazopanib in Patients with Clear-Cell Renal Cell Carcinoma: Seeking the Right Patient
por: Porta, Camillo, et al.
Publicado: (2017)

Insulin-like growth factor-1 signaling in renal cell carcinoma
por: Tracz, Adam F., et al.
Publicado: (2016)

Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in  Clear - Cell Renal Cell Carcinoma (ccRCC)
por: Bielecka, Zofia F., et al.
Publicado: (2013)

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma
por: Chrom, Pawel, et al.
Publicado: (2018)

Colony, hanging drop, and methylcellulose three dimensional hypoxic growth optimization of renal cell carcinoma cell lines
por: Matak, Damian, et al.
Publicado: (2017)

Choosing the right cell line for renal cell cancer research
por: Brodaczewska, Klaudia K., et al.
Publicado: (2016)

Development of extracellular matrix supported 3D culture of renal cancer cells and renal cancer stem cells
por: Maliszewska-Olejniczak, Kamila, et al.
Publicado: (2018)

Involvement of the CB(2) cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma
por: Khan, Mohammed I., et al.
Publicado: (2018)

Insulin and insulin-like growth factors act as renal cell cancer intratumoral regulators
por: Solarek, Wojciech, et al.
Publicado: (2019)

Functional significance of CD105-positive cells in papillary renal cell carcinoma
por: Matak, Damian, et al.
Publicado: (2017)

Immune consequences of anti-angiogenic therapyin renal cell carcinoma
por: Brodaczewska, Klaudia K., et al.
Publicado: (2018)

Renin angiotensin system deregulation as renal cancer risk factor
por: Sobczuk, Paweł, et al.
Publicado: (2017)

Axitinib in sequential therapy in metastatic renal cell carcinoma
por: Kuchar, Agata, et al.
Publicado: (2016)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – apoptosis-regulating factors
por: Młot, Beata, et al.
Publicado: (2012)

Seeking new prognostic and predictive factors in patients with metastatic renal cell carcinoma – hypoxia-induced factors
por: Młot, Beata, et al.
Publicado: (2012)

Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance
por: Klemba, Aleksandra, et al.
Publicado: (2018)

The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory
por: Khan, Mohammed I., et al.
Publicado: (2016)

Renal carcinoma CD105−/CD44− cells display stem-like properties in vitro and form aggressive tumors in vivo
por: Fiedorowicz, M., et al.
Publicado: (2020)

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model
por: Chrom, Pawel, et al.
Publicado: (2018)

Hypoxic 3D in vitro culture models reveal distinct resistance processes to TKIs in renal cancer cells
por: Bielecka, Zofia F., et al.
Publicado: (2017)

Chromophobe renal cell cancer - review of the literature and potential methods of treating metastatic disease
por: Stec, Rafał, et al.
Publicado: (2009)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

The Role of the Mitochondrial Genome in Ageing and Carcinogenesis
por: Czarnecka, Anna M., et al.
Publicado: (2011)

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy
por: Kade, Grzegorz, et al.
Publicado: (2012)

Choosing The Right Animal Model for Renal Cancer Research()
por: Sobczuk, Paweł, et al.
Publicado: (2020)

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial
por: Eisen, Tim, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_j1gqaqihgpttm5bdcsra84j970